澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

PYC THERAPEUTICS LTD

1.500

0.000

成交量：139.19万

成交额：209.37万

市值：14.07亿

市盈率：-14.92

高：1.550

开：1.510

低：1.490

收：1.500

52周最高：1.755

52周最低：0.847

股本：9.38亿

流通股本：3.48亿

量比：0.92

换手率：0.40%

股息：- -

股息率：- -

每股收益(TTM):-0.101

每股收益(LYR):-0.101

净资产收益率：-40.64%

总资产收益率：-24.42%

市净率：8.30

市盈率(LYR):-14.92

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

PYC Therapeutics宣布融资6.53亿澳元每股定价1.50澳元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/PYC.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","market":"AU","secType":"STK","nameCN":"PYC THERAPEUTICS LTD","latestPrice":1.5,"timestamp":1771823520000,"preClose":1.5,"halted":0,"volume":1391933,"delay":0,"changeRate":0,"nameEN":"PYC THERAPEUTICS LTD","floatShares":348081085,"shares":938042648,"eps":-0.100508,"marketStatus":"未开盘","change":0,"latestTime":"02-23 16:12:00 AEDT","open":1.51,"high":1.55,"low":1.49,"amount":2093690,"amplitude":0.04,"askPrice":1.545,"askSize":30000,"bidPrice":1.495,"bidSize":41173,"shortable":3,"etf":0,"ttmEps":-0.100508,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771887600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.5,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":0.92479,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","floatShares":348081085,"roa":"-24.42%","roe":"-40.64%","lyrEps":-0.100508,"volumeRatio":0.92479,"shares":938042648,"dividePrice":0,"high":1.55,"amplitude":0.04,"preClose":1.5,"low":1.49,"week52Low":0.847,"pbRate":"8.30","psRate":"59.89","week52High":1.755,"institutionHeld":0,"latestPrice":1.5,"committee":0.156984,"eps":-0.100508,"divideRate":0,"volume":1391933,"delay":0,"ttmEps":-0.100508,"open":1.51,"prevYearClose":1.655,"prevWeekClose":1.5,"prevMonthClose":1.6,"prevQuarterClose":1.655,"fiveDayClose":1.505,"twentyDayClose":1.685,"sixtyDayClose":1.47,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-15","symbol":"PYC.AU","defaultRemindTime":1731625200000,"type":"split","dateTimestamp":1731589200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2024-03-18","symbol":"PYC.AU","defaultRemindTime":1710716400000,"type":"split","dateTimestamp":1710680400000,"forFactor":988235,"toFactor":1000000,"ratio":0.988235}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYC.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1111159757","title":"PYC Therapeutics宣布融资6.53亿澳元 每股定价1.50澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111159757","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111159757?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 17:08","pubTimestamp":1770023311,"startTime":"0","endTime":"0","summary":"2月2日——生物技术公司PYC Therapeutics Ltd公布新一轮融资方案，计划以每股1.50澳元的价格募集最高达6.53亿澳元资金。此次融资将用于推进公司创新疗法管线的临床开发。作为澳大利亚证券交易所上市公司，PYC Therapeutics专注于开发针对遗传性眼病和癌症的RNA靶向疗法。该融资方案预计将增强公司的资本结构，为后续临床试验提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYC.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PYC.AU\",params:#limit:6,delay:true,,,undefined,":[]}}